MATERIALIZING SOLUTIONS
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Oct 2025)
What this means for you
This application is over — abandoned 08 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90501795
- Mark type
- Stylized text
- Filed
- 01 Feb 2021
- Published for opposition
- 07 Dec 2021
- Abandoned
- 08 Oct 2025
- Attorney of record
- William E. Anderson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the nature of implantable materials, namely, pliable, synthetic hydrogel for medical and surgical purposes; pharmaceutical preparations in the nature of implantable materials, namely, pliable, synthetic hydrogel for embolization therapy in interventional radiology and oncology; pharmaceutical preparations, namely, differentiated liquid embolics for interventional radiology; embolic agents delivered through a microcatheter under fluoroscopic control; kits that contain precursors that react to form a hydrogel when combined with each other and applicators therefore for use in medical and surgical procedures; system for vascular embolization procedures, namely, a embolization therapy system, featuring hydrogel precursors and applicator; a kit for vascular embolization procedures, featuring hydrogel precursors and applicator
- Class 010 — Medical apparatus: Surgical apparatuses and instruments; embolic device for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; arterial embolectomy device; medical device for embolization therapy in interventional radiology and oncology; embolic devices in the nature of liquid embolics delivered through microcatheter systems for interventional radiology, namely, interventional oncology and peripheral hemostasis; medical device for vascular embolization procedures; medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, organs and segmental embolizations; in situ polymerizing hydrogel-based medical devices for the treatment of anomalies in the vasculature of the body
Owner
- Instylla Inc., Bedford, MA, US
- Instylla Inc., Bedford, MA, US
Prosecution history
- 08 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Aug 2024 — SOU EXTENSION 5 GRANTED
- 01 Aug 2024 — SOU EXTENSION 5 FILED
- 01 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Feb 2024 — SOU EXTENSION 4 GRANTED
- 01 Feb 2024 — SOU EXTENSION 4 FILED
- 01 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 03 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Aug 2023 — SOU EXTENSION 3 GRANTED
- 01 Aug 2023 — SOU EXTENSION 3 FILED
- 01 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 01 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED